Characterization of Different Inflammatory Skin Conditions in a Mouse Model of DNCB-Induced Atopic Dermatitis

Bibliographic Details
Title:	Characterization of Different Inflammatory Skin Conditions in a Mouse Model of DNCB-Induced Atopic Dermatitis
Authors:	Riedl, Rebecca, Kühn, Annika, Hupfer, Yvonne, Hebecker, Betty, Peltner, Lukas K., Jordan, Paul M., Werz, Oliver, Lorkowski, Stefan, Wiegand, Cornelia, Wallert, Maria
Source:	http://lobid.org/resources/99370671252406441#!, 47(2):771-788.
Publication Year:	2023
Collection:	Publisso (ZB MED-Publikationsportal Lebenswissenschaften)
Subject Terms:	Dermatitis, Atopic/chemically induced [MeSH], 2,4-dinitrochlorobenzene, Atopic/pathology [MeSH], Female [MeSH], Filaggrin Proteins [MeSH], Mice, Inbred BALB C [MeSH], Inflammation/chemically induced [MeSH], atopic dermatitis mouse model, Skin/drug effects [MeSH], sub-acute and chronic inflammation, Cytokines/metabolism [MeSH], Animals [MeSH], Skin/pathology [MeSH], Atopic/metabolism [MeSH], Mice [MeSH], Research, Dinitrochlorobenzene/toxicity [MeSH], Inflammation/metabolism [MeSH], Disease Models, Animal [MeSH], mild and moderate atopic dermatitis, Dexamethasone/pharmacology [MeSH], Skin/metabolism [MeSH]
Description:	AbstractThe mouse model of 2,4-dinitrochlorbenzene (DNCB)-induced human-like atopic dermatitis (hlAD) has been widely used to test novel treatment strategies and compounds. However, the study designs and methods are highly diverse, presenting different hlAD disease patterns that occur after sensitization and repeated challenge with DNCB on dorsal skin. In addition, there is a lack of information about the progression of the disease during the experiment and the achieved pheno- and endotypes, especially at the timepoint when therapeutic treatment is initiated. We here examine hlAD in a DNCB-induced BALB/cJRj model at different timepoints: (i) before starting treatment with dexamethasone, representing a standard drug control (day 12) and (ii) at the end of the experiment (day 22). Both timepoints display typical AD-associated characteristics: skin thickening, spongiosis, hyper- and parakeratosis, altered cytokine and gene expression, increased lipid mediator formation, barrier protein and antimicrobial peptide abnormalities, as well as lymphoid organ hypertrophy. Increased mast cell infiltration into the skin and elevated immunoglobulin E plasma concentrations indicate a type I allergy response. The DNCB-treated skin showed an extrinsic moderate sub-acute hlAD lesion at day 12 and an extrinsic mild sub-acute to chronic pheno- and endotype at day 22 with a dominating Th2 response. A dependency of the filaggrin formation and expression in correlation to the disease severity in the DNCB-treated skin was found. In conclusion, our study reveals a detailed classification of a hlAD at two timepoints with different inflammatory skin conditions and pheno- and endotypes, thereby providing a better understanding of the DNCB-induced hlAD model in BALB/cJRj mice.
Document Type:	article in journal/newspaper
Language:	English
Relation:	https://repository.publisso.de/resource/frl:6504113; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074229/
DOI:	10.1007/s10753-023-01943-x
Availability:	https://repository.publisso.de/resource/frl:6504113 https://doi.org/10.1007/s10753-023-01943-x https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074229/
Rights:	https://creativecommons.org/licenses/by/4.0/
Accession Number:	edsbas.7E2FABDF
Database:	BASE

View record from BASE

Be the first to leave a comment!